Literature DB >> 18992375

Impairment of cerebello-thalamo-frontal pathway in Rab-GDI mutated patients with pure mental deficiency.

Aurore Curie1, Silvia Sacco, Gérald Bussy, Anne de Saint Martin, Nathalie Boddaert, Sandra Chanraud, Isabelle Meresse, Jamel Chelly, Monica Zilbovicius, Vincent des Portes.   

Abstract

BACKGROUND: Rab-GDI mutations are responsible for "pure" mental deficiency, without any specific clinical features or brain malformation. Therefore, screening for mutations in mentally retarded patients is not available on a routine basis. Moreover, neuronal networks involved in mental deficiency still remain largely unknown.
METHODS: We performed a fine neuropsychological and imaging study in five patients from two unrelated families, affected with mental deficiency due to a mutation in the Rab-GDI gene. High resolution 3D brain MRI of the five mentally retarded adult males (mean age 33 years) were compared to MRI of 14 healthy males (mean age 35 years) using a Voxel-Based Morphometric analysis (VBM).
RESULTS: All patients had isolated moderate mental retardation (WAIS-III IQ range, 41-50; mean 45) without specific morphological or behavioural features. No obvious brain abnormality was observed on visual inspection of individual scans. Using VBM analysis, Rab-GDI mutated patients' MRIs exhibited significant brain changes compared to normal subjects (p<0.05, corrected for multiple comparisons): increased grey matter density in left cerebellum and in left angular gyrus, decreased grey matter volume in thalami, decreased white matter density in prefrontal lobes, right fusiform occipito-temporal gyrus, and decreased white matter volume in cerebellar peduncles.
CONCLUSIONS: These morphological changes observed in Rab-GDI mutated patients, mainly localized in the cerebello-thalamo-prefrontal pathway, are consistent with the hypothesis that the cerebellum is one of the critical components of a global learning network. Our results open new avenues in the diagnosis of non-specific mental deficiency using gene-specific "brain maps" as endophenotypes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992375     DOI: 10.1016/j.ejmg.2008.09.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  5 in total

1.  The role of the thalamus in neuro-cognitive dysfunction in early unilateral hemispheric injury: a multimodality imaging study of children with Sturge-Weber syndrome.

Authors:  Bálint Alkonyi; Harry T Chugani; Michael Behen; Stacey Halverson; Emily Helder; Malek I Makki; Csaba Juhász
Journal:  Eur J Paediatr Neurol       Date:  2010-05-05       Impact factor: 3.140

2.  Proteomic analysis of adrenocorticotropic hormone treatment of an infantile spasm model induced by N-methyl-D-aspartic acid and prenatal stress.

Authors:  Jing Wang; Juan Wang; Ying Zhang; Guang Yang; Wen-Jing Zhou; Ai-Jia Shang; Li-Ping Zou
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

3.  Two Metabolic Fuels, Glucose and Lactate, Differentially Modulate Exocytotic Glutamate Release from Cultured Astrocytes.

Authors:  Vedrana Montana; Daniel Flint; Helle S Waagepetersen; Arne Schousboe; Vladimir Parpura
Journal:  Neurochem Res       Date:  2021-05-31       Impact factor: 4.414

4.  Altered fronto-striatal functions in the Gdi1-null mouse model of X-linked Intellectual Disability.

Authors:  Lorenzo Morè; Basil Künnecke; Latefa Yekhlef; Andreas Bruns; Antonella Marte; Ernesto Fedele; Veronica Bianchi; Stefano Taverna; Silvia Gatti; Patrizia D'Adamo
Journal:  Neuroscience       Date:  2017-01-03       Impact factor: 3.590

5.  Basal ganglia involvement in ARX patients: The reason for ARX patients very specific grasping?

Authors:  Aurore Curie; Gaëlle Friocourt; Vincent des Portes; Alice Roy; Tatjana Nazir; Amandine Brun; Anne Cheylus; Pascale Marcorelles; Kalliroi Retzepi; Nasim Maleki; Gérald Bussy; Yves Paulignan; Anne Reboul; Danielle Ibarrola; Jian Kong; Nouchine Hadjikhani; Annie Laquerrière; Randy L Gollub
Journal:  Neuroimage Clin       Date:  2018-04-05       Impact factor: 4.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.